更正：在卵巢癌小鼠模型中，程序性死亡蛋白1（PD-1）阻断与OX40激活协同作用可有效抑制肿瘤生长 。
Correction: PD-1 Blockade and OX40 Triggering Synergistically Protects against Tumor Growth in a Murine Model of Ovarian Cancer.
作者信息
Guo Zhiqiang, Wang Xin, Cheng Dali, Xia Zhijun, Luan Meng, Zhang Shulan
出版信息
PLoS One. 2017 Oct 18;12(10):e0186965. doi: 10.1371/journal.pone.0186965. eCollection 2017.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0089350.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0089350。]
相似文献
1
Correction: PD-1 Blockade and OX40 Triggering Synergistically Protects against Tumor Growth in a Murine Model of Ovarian Cancer.更正：在卵巢癌小鼠模型中，程序性死亡蛋白1（PD-1）阻断与OX40激活协同作用可有效抑制肿瘤生长 。
PLoS One. 2017 Oct 18;12(10):e0186965. doi: 10.1371/journal.pone.0186965. eCollection 2017.
2
3
Correction: Pre-Treatment with Amifostine Protects against Cyclophosphamide-Induced Disruption of Taste in Mice.更正：氨磷汀预处理可预防环磷酰胺诱导的小鼠味觉障碍。
PLoS One. 2013 Jul 31;8(7). doi: 10.1371/annotation/5487e265-8175-47cb-b9a4-d85862a4a96f. eCollection 2013.
4
Correction: Lifelong aerobic exercise protects against inflammaging and cancer.更正：终身有氧运动可预防炎症衰老和癌症。
PLoS One. 2020 May 13;15(5):e0233401. doi: 10.1371/journal.pone.0233401. eCollection 2020.
5
Correction: Survivin Mutant Protects Differentiated Dopaminergic SK-N-SH Cells Against Oxidative Stress.更正：生存素突变体保护分化的多巴胺能SK-N-SH细胞免受氧化应激。
PLoS One. 2018 Mar 15;13(3):e0194587. doi: 10.1371/journal.pone.0194587. eCollection 2018.
6
Correction: Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin.更正：阿利吉仑与帕立骨化醇联合治疗通过双重阻断肾内肾素对进行性肾小管间质纤维化有效。
PLoS One. 2018 May 1;13(5):e0196885. doi: 10.1371/journal.pone.0196885. eCollection 2018.
7
Correction: Cystathionine-Gamma-Lyase Gene Deletion Protects Mice against Inflammation and Liver Sieve Injury following Polymicrobial Sepsis.更正：胱硫醚-γ-裂合酶基因缺失保护小鼠免受多微生物败血症后的炎症和肝筛损伤。
PLoS One. 2017 Aug 10;12(8):e0183304. doi: 10.1371/journal.pone.0183304. eCollection 2017.
8
Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.更正：用于检测BRCA1突变携带者中卵巢癌的诊断标志物。
PLoS One. 2018 Apr 17;13(4):e0196142. doi: 10.1371/journal.pone.0196142. eCollection 2018.
9
Correction: Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms.更正：使用22C3抗PD-L1抗体在多个自动免疫组织化学平台上测定PD-L1表达。
PLoS One. 2017 Oct 13;12(10):e0186537. doi: 10.1371/journal.pone.0186537. eCollection 2017.
10
Correction: Tongxinluo protects against pressure overload-induced heart failure in mice involving VEGF/Akt/eNOS pathway activation.更正：通心络通过激活VEGF/Akt/eNOS通路对小鼠压力超负荷诱导的心力衰竭起到保护作用。
PLoS One. 2019 Aug 1;14(8):e0220845. doi: 10.1371/journal.pone.0220845. eCollection 2019.
引用本文的文献
1
Current Clinical Trial Landscape of OX40 Agonists.OX40 激动剂的当前临床试验格局。
Curr Oncol Rep. 2022 Jul;24(7):951-960. doi: 10.1007/s11912-022-01265-5. Epub 2022 Mar 29.
2
The Perfect Combination: Enhancing Patient Response to PD-1-Based Therapies in Epithelial Ovarian Cancer.完美组合：增强上皮性卵巢癌患者对基于PD-1疗法的反应
Cancers (Basel). 2020 Aug 3;12(8):2150. doi: 10.3390/cancers12082150.
本文引用的文献
1
PD-1 blockade and OX40 triggering synergistically protects against tumor growth in a murine model of ovarian cancer.在卵巢癌小鼠模型中，程序性死亡受体1（PD-1）阻断与OX40激活协同作用可有效抑制肿瘤生长。
PLoS One. 2014 Feb 27;9(2):e89350. doi: 10.1371/journal.pone.0089350. eCollection 2014.
Zotero 插件